Amphetamines - PMCOL Midterm 2 PDF

Summary

This document provides an overview of amphetamines, including their learning objectives, potency, synthesis, neurotransmitter effects, adverse effects, and mechanisms of action. It also discusses tolerance and withdrawal symptoms.

Full Transcript

‭Amphetamines‬ ‭Learning objectives:‬ ‭Ma huang‬ ‭ hinese medicine herb from which amphetamines‬ C ‭are derived‬ ‭Edeleanu‬ ‭ erson who synthesized alpha‬...

‭Amphetamines‬ ‭Learning objectives:‬ ‭Ma huang‬ ‭ hinese medicine herb from which amphetamines‬ C ‭are derived‬ ‭Edeleanu‬ ‭ erson who synthesized alpha‬ P ‭methylphenethylamine (AMPH) to treat asthma‬ ‭Potency of Amphetamines‬ ‭Least potent → most potene‬ ‭1)‬ ‭L-amphetamine‬ ‭2)‬ ‭D-amphetamine‬ ‭3)‬ ‭methamphetamine‬ ‭AMPHs vs neurotransmitter chemistry‬ ‭ ETH = phenyl‬ M ‭DA = phenol‬ ‭AMPH = phenylethylamine‬ ‭NE = catecholamine‬ ‭Structural similarity allows amphetamines to bind‬ ‭nt transporters‬ ‭How is meth synthesized‬ ‭Nagai or Leuckart synthesis‬ ‭AMPH ADME‬ ‭ :‬‭ingested (70%), injected, snorted (80%), or‬ A ‭smoked (70-99%) (smoking is the fastest onset)‬ ‭Ice (HCl salt smokable form) has a 12 hour t‬‭1/2‬‭,‬ ‭Longer lasting high than cocaine‬ ‭D:‬‭30-120 min‬ ‭M:‬‭Slower metabolism,‬‭CYP2D6‬‭metabolizes‬ ‭METH (12+ h t‬‭1/2‬‭, 10-20 h duration) and AMPH‬ ‭(~11 h t‬‭1/2‬‭, 3-12 h duration)‬ ‭E:‬‭kidney, sweat, saliva → eliminate active‬ ‭metabolites (Norephedrine and 4-HA)‬ ‭Acute & Adverse effects of AMPH‬ ‭ cute:‬ A ‭Increased NE release → Sympathomimetic‬ ‭Increased 5HT release → delusional parasitosis‬ ‭and perceptual disturbances‬ ‭Increased DA → locomotor activity ie. punding‬ ‭Adverse:‬ ‭Poisoning from contaminants‬ ‭Polypharmacy → enhance stimulatory effects‬ ‭Cellular mechanisms of AMPH‬ ‭ levate DA, NE, 5HT availability‬ E ‭Does‬‭not‬‭require DA-ergic neuron firing‬ ‭Enter via DAT or diffusion‬ ‭1)‬ ‭Block reuptake via DATs, NETs, & SERTs‬ ‭a)‬ ‭AMPH-TAAR complex and‬ ‭cytoplasmic DA build-up reverse‬ ‭the DAT‬ ‭b)‬ ‭Can leak into synapse‬ ‭c)‬ ‭DA spike can cause post-synaptic‬ ‭cell activation‬ ‭ )‬ ‭Increase release into synapse‬ 2 ‭3)‬ ‭Inhibit MAOs at high concentrations‬ ‭Cause DA surge in basal ganglia‬ ‭Small which allows transporter to complete‬ ‭transport → doesn’t lock the transporter‬ ‭Tolerance of AMPH‬ ‭ epletion via displacement (5HT, DA, NE)‬ D ‭Inhibition of tyrosine hydroxylase (reduced NE and‬ ‭DA synthesis)‬ ‭Acute dosing reduces DAT function‬ ‭Reverse tolerance targets motor function ganglia‬ ‭Withdrawal of AMPH‬ ‭Physical and psychological withdrawal‬ ‭-‬ ‭Craving, depression, lethargy, muscle‬ ‭pain, abnormal sleep‬ ‭-‬ ‭Anhedonia, emotional volatility‬ ‭-‬ ‭Degree and duration depends on dosing‬ ‭Dependence of AMPH‬ ‭ hronic dosing causes reduced cell-surface‬ C ‭expression of DA and NE transporters‬ ‭-‬ ‭Upstream TAAR activation‬ ‭-‬ ‭TAAR1 knockout mice = more sensitive to‬ ‭DA activation‬ ‭-‬ ‭TAAR1 agonists reduce effects of‬ ‭AMPHS‬ ‭ ow do long-term brain effects of AMPH‬ H -‭ ‬ ‭ eight loss‬ W ‭effects other conditions‬ ‭-‬ ‭Skin breakdown‬ ‭-‬ ‭Sores, picking‬ ‭-‬ ‭Meth mouth‬ ‭-‬ ‭Exaggerated psych effects →‬ ‭sensitization → unprovoked aggression,‬ ‭anxiety, homi/suicidal thoughts‬ ‭-‬ ‭DA depletion in movement (BG), memory‬ ‭(Hippo), and decision making (PFC)‬ ‭-‬ ‭Damage to DA, NE, 5HT terminals →‬ ‭excitotoxicity stresses neurons and‬ ‭induces cell death → brain damage‬ ‭-‬ ‭Measured by reduced volume‬ ‭-‬ ‭DAT levels may recover, but function may‬ ‭not → impacts anticipation and craving‬ -‭ ‬ ‭Most significant loss in‬‭cingulate gyrus‬ ‭-‬ ‭Loss of DA-ergic neurons predisposes‬ ‭METH addicts to developing Parkinsons‬ ‭-‬ ‭AMPH may trigger‬‭nAChRs‬‭→ allows CA‬ ‭influx → form ROS and cellular stress‬ ‭-‬ ‭Blocked by nAChR antagonists‬ ‭Meth mouth and toxic mechanisms‬ ‭ ooth decay, jaw grinding tic‬ T ‭Activate α1 receptors on vessels→ vessel‬ ‭constriction‬ ‭Activate presynaptic α2 receptors on salivary‬ ‭glands → reduced saliva production‬ ‭Keywords:‬ ‭Ma huang‬ ‭ hinese medicine herb from which amphetamines‬ C ‭are derived‬ ‭Edeleanu‬ ‭ erson who synthesized alpha‬ P ‭methylphenethylamine (AMPH) to treat asthma‬ ‭stereochemistry‬ ‭1)‬ L ‭ -amphetamine = decongestant, raise BP,‬ ‭cause headache‬ ‭2)‬ ‭D-amphetamine = elevate mood and‬ ‭enhance energy, same effects as L-amph‬ ‭3)‬ ‭Meth = has methyl group which increases‬ ‭lipophilicity = increased potency and‬ ‭psychoactivity‬ ‭a)‬ ‭Crosses BBB, enters NAc,‬ ‭increase DA release‬ ‭Nagai‬ ‭ ynthesis of METH from pseudoephedrine or‬ S ‭ephedrine‬ ‭Leuckart‬ ‭ eductive amination to make METH from‬ R ‭phenylacetone‬ ‭TAAR‬ I‭ntracellular GPCR, activated by 4-HA, stimulates‬ ‭NE release, inhibits MAO (MAO degrades‬ ‭monoamines)‬ ‭Activates phosphorylation dependent signalling‬ ‭that targets the DAT to reverse transport‬ ‭Regulatory role regarding DA activation‬ ‭parasitosis‬ ‭ eeling of bugs under skin as a result of increased‬ F ‭5HT release influences perceptions‬ ‭punding‬ ‭ epetitive meaningless behaviours as a result of‬ R ‭too much DA leading to decreased selectivity of‬ ‭basal ganglia activity‬ ‭DAT‬ ‭Brings meth into nerve terminals‬ ‭VMAT‬ ‭ esicular monoamine transporter: pump meth into‬ V ‭storage vesicles‬ ‭MAO‬ ‭ onoamine oxidase: degrade monoamine NTs‬ M ‭such as DA, NE, and 5HT‬ ‭anhedonia‬ i‭nability to feel pleasure – psychological effect of‬ ‭withdrawal‬ ‭Meth mouth‬ ‭Tooth decay, jaw grinding tic‬ ‭nAChRs‬ ‭ icotinic acetylcholine receptors‬ N ‭May be triggered by AMPH, lead to ROS‬ ‭production and cellular stress‬

Use Quizgecko on...
Browser
Browser